Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
LP.8.1 variant adapted COVID-19 vaccine COMIRNATY is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks. This season's ...
With the approval of ABRYSVO® for adults aged 18+, there is now a way to help protect against RSV in a population that previously did not have vaccination options. KIRKLAND, QC, Oct. 21, 2025 /CNW/ - ...
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
OTTAWA, Dec 3 (Reuters) - Canadian health authorities could approve Pfizer Inc's (PFE.N), opens new tab coronavirus vaccine within the next week, allowing distribution to start in early 2021, medical ...
Pfizer is starting to export U.S.-made doses of its COVID-19 vaccine to Canada and Mexico, the first exports of its shots from the United States, according to reports. Canada will start getting Pfizer ...
MONTREAL, Nov. 6, 2025 /CNW/ - The Canadian Paralympic Committee (CPC) and Pfizer Canada have extended their partnership, with 2026 marking 30 years of working together to support and promote ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
This week, the FDA approved a label change on Depo Provera, requiring its maker, Pfizer, to warn women about links between use of the birth control injection and brain tumors known as meningiomas. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results